The RXi Mini System will debut at the 29th Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in Denver, Colorado. The RXi Mini is designed to provide fractional flow reserve (FFR) measurements to complement angiography, provide qualitative assessment of lesion severity, and inform intervention strategy in both diagnosis and treatment of coronary and peripheral artery disease.
Condensed abstract. CONTRACT is an investigator-initiated, prospective, single-center, observational cohort study that evaluated whether the RXi Navvus system compared to the use of standard Fractional Flow Reserve (FFR) wires reduces total contrast volume, radiation and overall study cost in a real world patient population referred for coronary angiography or percutaneous coronary intervention.Aims: The present report describes a novel coronary fractional flow reserve (FFR) system which allows FFR assessment using a rapid exchange microcatheter (RXi). Methods and results: The RXi microcatheter is compatible with standard 0.014” coronary guidewires facilitating lesion negotiation and FFR assessment in a wide range of coronary anatomies.In 2014, the company launched the Acist RXi rapid exchange FFR system and the Navvus rapid exchange FFR microcatheter. The FFR Study data results, along with the ACCESS-NZ Trial results (used for both US Food and Drug Administration clearance and European CE Mark approval), will seek to further demonstrate the clinical utility of the Navvus FFR device in everyday practice.
The new Rapid FFR system utilizes the ultra-thin Acist Navvus Rapid Exchange MicroCatheter and RXi console. The Navvus MicroCatheter can be used over a standard 0.014-inch guidewire, providing the physician maximum control while maintaining wire position throughout the coronary procedure.
Find paid internships, part-time jobs and entry-level opportunities at thousands of startups and Fortune 500s. Use our resources for tips on interviews, resumes, cover letters and more.
This device features new technology designed to provide physicians with a fast and easy way to perform Fractional Flow Reserve (FFR) procedures. The new Rapid FFR system utilizes.
Nov 13, 2014 - Once the wire is in place, I have yet to do a case where I have not been able to cross with the catheter. It is a much more user-friendly device than the wire-based systems.
New fractional flow reserve system enters global market ACIST Medical Systems has announced the global introduction of its RXi rapid exchange fractional flow reserve system, a first-of-its-kind technology, according to a press release.The device utilizes the ultrathin ACIST Navvus rapid exchange microcatheter and RXi console.
The RXi system also facilitates rapid FFR assessments before, during and post-intervention, to quickly assess blockages that could require Percutaneous Coronary Intervention (PCI).This unique technology is the first of its kind, providing the reassurance of accurate and reliable FFR measurements and the advantages of Rapid Exchange technology.
BACKGROUND: FFR is the mainstay of functional hemodynamic assessment of coronary artery lesions. The RXi Navvus system (ACIST Medical Systems, Eden Prairie, MN) is a monorail microcatheter with.
The technology in the RXi Rapid Exchange FFR System will continue to evolve and advance our mission to simplify the complexities in the Cath Lab.” ACIST received FDA clearance for the RXi system.
Fractional flow reserve (FFR) is a technique used in coronary catheterization to measure pressure differences across a coronary artery stenosis (narrowing, usually due to atherosclerosis) to determine the likelihood that the stenosis impedes oxygen delivery to the heart muscle (myocardial ischemia). Fractional flow reserve is defined as the pressure after (distal to) a stenosis relative to.
TCT 2017: Next-generation FFR system launched 8th November 2017 Acist has announced the global launch of its RXi Mini system—the next-generation system of its RXi Rapid Exchange fractional flow reserve (FFR) system.
ACIST Medical Systems has announced the global introduction of its RXi rapid exchange fractional flow reserve system, a first-of-its-kind technology, according to a press release.The device.
A New Rapid Exchange MicroCatheter Approach to FFR Based on an interview with Dr. Madhav Menon of Waikato District Health Board, Hamilton, New Zealand.
The RXi system also facilitates rapid FFR assessments before, during and post-intervention, to quickly assess blockages that could require PCI. This unique technology is the first of its kind, providing the reassurance of accurate and reliable FFR measurements and the advantages of Rapid Exchange technology.